Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 May 8:25:3406-3416.
doi: 10.12659/MSM.916423.

Improving the Surgical Effect for Primary Liver Cancer with Intraoperative Fluorescence Navigation Compared with Intraoperative Ultrasound

Affiliations
Comparative Study

Improving the Surgical Effect for Primary Liver Cancer with Intraoperative Fluorescence Navigation Compared with Intraoperative Ultrasound

Bing Liu et al. Med Sci Monit. .

Abstract

BACKGROUND This study aimed to compare the application value of intraoperative fluorescence navigation technology (FNT) and intraoperative ultrasound (IOUS) in primary liver cancer surgery. MATERIAL AND METHODS Fifty consecutive patients with primary liver cancer scheduled to receive surgical treatment were divided into FNT group and IOUS group. FNT and IOUS were separately used to guide tumor resection and detect new cancerous lesions in the 2 groups. The complete tumor resection rate (R0) resection rate, length of the tumor distance from cutting edge, the diagnostic efficacy of cancerous nodules and the fluorescence imaging characteristics of different types tumors were recorded. RESULTS The R0 resection rate was 100% (25 out of 25 patients) in the FNT group and 96% (24 out of 25 patients) in the IOUS group. In the FNT group, 1 case (4%, 1 out of 25 patients) had cancer tissue that was less than 1 cm from the cutting edge, compared to 7 cases (28%, 7 out of 25 patients) in the IOUS group (P=0.049), which was a significant difference. In the remaining livers of 50 consecutive patients, FNT found 5 new cancerous nodules with a sensitivity of 71.4%, a specificity of 11.1%, and a false-positive rate of 88.9%; for IOUS the results were 42.9%, 88.9%, 11.1%. The fluorescence imaging characteristics of all well-differentiated hepatocellular carcinomas were tumor tissue imaging, but all other types of tumors were ring imaging around the tumor. CONCLUSIONS FNT can improve the R0 resection rate, ensure a safe distance between tumor and cutting edge and can identify more new cancerous nodules compared to IOUS. Thus, FNT could improve the surgical treatment effect for primary liver cancer and hopefully further improve the prognosis of patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of research procedure.
Figure 2
Figure 2
(A/a, B/b, C/c) In a male 52-year-old patient, the tumor was located at the junction of S4, S5, and S8 segments of the liver. (A/a) Direct vision and fluorescence imaging image of the liver surface. (B/b, C/c) Direct vision and fluorescence imaging images of the isolated specimens, in which ICG residues were detected in the gallbladder. (D/d) In a female 61-year-old patient, the tumor was located in the right liver. After resection of the tumor by conventional surgery, fluorescence imaging was used to detect the suspected lesion at the resection margin of the liver. (E/e) In a male 51-year-old patient, the tumor was located under the liver capsule, the size was approximately 2.0×1.5×0.9 cm, the pathological result was highly differentiated hepatocellular carcinoma, and fluorescence imaging was characterized by tumor tissue imaging. (F/f) In a male 72-year-old patient, tumor in S8 segment, size 6.0×5.0×3.5 cm, medium-low differentiated cholangiocarcinoma, fluorescence imaging characteristics of peripheral imaging.

References

    1. Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR. Surgical management of hepatocellular carcinoma: is the jury still out? Surg Oncol. 2009;18(4):298–321. - PubMed
    1. Yuichi N, Ishizawa Takeaki, Akio S. Fluorescence-guided surgery for liver tumors. J Surg Oncol. 2018;118:324–31. - PubMed
    1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–91. - PMC - PubMed
    1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004;127(Suppl 1):S5–S16. - PubMed
    1. Giannini EG, Farinati F, Ciccarese F, et al. Prognosis of untreated hepatocellular carcinoma. Hepatology. 2015;61:184–90. - PubMed

Publication types

MeSH terms